LANXESS AG (LXS.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:LXS - DE0005470405 - Common Stock
17.08 EUR
-0.08 (-0.47%)
Overall LXS gets a fundamental rating of 3 out of 10. We evaluated LXS against 75 industry peers in the Chemicals industry. LXS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LXS has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
LXS had positive earnings in the past year.
In the past year LXS had a positive cash flow from operations.
Of the past 5 years LXS 4 years were profitable.
Each year in the past 5 years LXS had a positive operating cash flow.
1.2 Ratios
The Return On Assets of LXS (-2.97%) is worse than 74.67% of its industry peers.
Looking at the Return On Equity, with a value of -6.23%, LXS is doing worse than 74.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.97% | ||
| ROE | -6.23% | ||
| ROIC | N/A |
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Operating Margin of LXS has declined.
LXS has a Gross Margin of 20.52%. This is in the lower half of the industry: LXS underperforms 70.67% of its industry peers.
In the last couple of years the Gross Margin of LXS has declined.
LXS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.52% |
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
2. Health
2.1 Basic Checks
LXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LXS remains at a similar level compared to 1 year ago.
LXS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LXS has been reduced compared to a year ago.
2.2 Solvency
LXS has an Altman-Z score of 1.88. This is not the best score and indicates that LXS is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of LXS (1.88) is worse than 69.33% of its industry peers.
The Debt to FCF ratio of LXS is 22.13, which is on the high side as it means it would take LXS, 22.13 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LXS (22.13) is comparable to the rest of the industry.
LXS has a Debt/Equity ratio of 0.62. This is a neutral value indicating LXS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.62, LXS is not doing good in the industry: 64.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 22.13 | ||
| Altman-Z | 1.88 |
ROIC/WACCN/A
WACC4.47%
2.3 Liquidity
LXS has a Current Ratio of 2.60. This indicates that LXS is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.60, LXS is doing good in the industry, outperforming 78.67% of the companies in the same industry.
LXS has a Quick Ratio of 1.29. This is a normal value and indicates that LXS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.29, LXS is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.6 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
The earnings per share for LXS have decreased strongly by -10.28% in the last year.
LXS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.38% yearly.
The Revenue has decreased by -6.82% in the past year.
The Revenue has been decreasing by -1.32% on average over the past years.
EPS 1Y (TTM)-10.28%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-108.14%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-16.27%
3.2 Future
The Earnings Per Share is expected to grow by 6.37% on average over the next years.
Based on estimates for the next years, LXS will show a decrease in Revenue. The Revenue will decrease by -0.30% on average per year.
EPS Next Y-70.38%
EPS Next 2Y-25.3%
EPS Next 3Y2.65%
EPS Next 5Y6.37%
Revenue Next Year-9.53%
Revenue Next 2Y-5.14%
Revenue Next 3Y-2.44%
Revenue Next 5Y-0.3%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 17.79, LXS is valued on the expensive side.
68.00% of the companies in the same industry are more expensive than LXS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of LXS to the average of the S&P500 Index (26.59), we can say LXS is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 19.37, the valuation of LXS can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as LXS.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.03, LXS is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.79 | ||
| Fwd PE | 19.37 |
4.2 Price Multiples
LXS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LXS is cheaper than 82.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LXS indicates a rather cheap valuation: LXS is cheaper than 89.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.17 | ||
| EV/EBITDA | 5.93 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-25.3%
EPS Next 3Y2.65%
5. Dividend
5.1 Amount
With a yearly dividend of 0.59%, LXS is not a good candidate for dividend investing.
In the last 3 months the price of LXS has falen by -21.72%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
LXS's Dividend Yield is slightly below the industry average, which is at 2.58.
With a Dividend Yield of 0.59, LXS pays less dividend than the S&P500 average, which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.59% |
5.2 History
The dividend of LXS decreases each year by -35.08%.
Dividend Growth(5Y)-35.08%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
The earnings of LXS are negative and hence is the payout ratio. LXS will probably not be able to sustain this dividend level.
DP-4.12%
EPS Next 2Y-25.3%
EPS Next 3Y2.65%
FRA:LXS (12/23/2025, 7:00:00 PM)
17.08
-0.08 (-0.47%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners73.07%
Inst Owner ChangeN/A
Ins Owners2.86%
Ins Owner ChangeN/A
Market Cap1.47B
Revenue(TTM)5.89B
Net Income(TTM)-243.00M
Analysts56.3
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.59% |
Yearly Dividend0.1
Dividend Growth(5Y)-35.08%
DP-4.12%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)292.85%
Min EPS beat(2)79.47%
Max EPS beat(2)506.23%
EPS beat(4)4
Avg EPS beat(4)279.29%
Min EPS beat(4)79.47%
Max EPS beat(4)506.23%
EPS beat(8)8
Avg EPS beat(8)234.01%
EPS beat(12)11
Avg EPS beat(12)164.45%
EPS beat(16)14
Avg EPS beat(16)126.78%
Revenue beat(2)0
Avg Revenue beat(2)-8.07%
Min Revenue beat(2)-8.49%
Max Revenue beat(2)-7.66%
Revenue beat(4)0
Avg Revenue beat(4)-5.7%
Min Revenue beat(4)-8.49%
Max Revenue beat(4)-1.78%
Revenue beat(8)1
Avg Revenue beat(8)-4.92%
Revenue beat(12)2
Avg Revenue beat(12)-4.05%
Revenue beat(16)3
Avg Revenue beat(16)-5.05%
PT rev (1m)-16.42%
PT rev (3m)-23.89%
EPS NQ rev (1m)4.32%
EPS NQ rev (3m)-0.67%
EPS NY rev (1m)-1.87%
EPS NY rev (3m)233.82%
Revenue NQ rev (1m)-1.82%
Revenue NQ rev (3m)-4.88%
Revenue NY rev (1m)-1.46%
Revenue NY rev (3m)-3.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.79 | ||
| Fwd PE | 19.37 | ||
| P/S | 0.25 | ||
| P/FCF | 13.17 | ||
| P/OCF | 3.41 | ||
| P/B | 0.38 | ||
| P/tB | 0.88 | ||
| EV/EBITDA | 5.93 |
EPS(TTM)0.96
EY5.62%
EPS(NY)0.88
Fwd EY5.16%
FCF(TTM)1.3
FCFY7.59%
OCF(TTM)5
OCFY29.29%
SpS68.19
BVpS45.2
TBVpS19.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number31.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.97% | ||
| ROE | -6.23% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.52% | ||
| FCFM | 1.9% |
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
F-Score6
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 22.13 | ||
| Debt/EBITDA | 4.55 | ||
| Cap/Depr | 50.71% | ||
| Cap/Sales | 5.43% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 81.82% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.6 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 1.88 |
F-Score6
WACC4.47%
ROIC/WACCN/A
Cap/Depr(3y)54.6%
Cap/Depr(5y)69.53%
Cap/Sales(3y)4.97%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.28%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-108.14%
EPS Next Y-70.38%
EPS Next 2Y-25.3%
EPS Next 3Y2.65%
EPS Next 5Y6.37%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-16.27%
Revenue Next Year-9.53%
Revenue Next 2Y-5.14%
Revenue Next 3Y-2.44%
Revenue Next 5Y-0.3%
EBIT growth 1Y82.42%
EBIT growth 3Y-48.45%
EBIT growth 5Y-38.23%
EBIT Next Year1009.97%
EBIT Next 3Y137.45%
EBIT Next 5Y75.06%
FCF growth 1Y-74.13%
FCF growth 3YN/A
FCF growth 5Y6.85%
OCF growth 1Y-44.97%
OCF growth 3Y7.67%
OCF growth 5Y-4.6%
LANXESS AG / LXS.DE FAQ
Can you provide the ChartMill fundamental rating for LANXESS AG?
ChartMill assigns a fundamental rating of 3 / 10 to LXS.DE.
What is the valuation status for LXS stock?
ChartMill assigns a valuation rating of 4 / 10 to LANXESS AG (LXS.DE). This can be considered as Fairly Valued.
What is the profitability of LXS stock?
LANXESS AG (LXS.DE) has a profitability rating of 2 / 10.
What is the financial health of LANXESS AG (LXS.DE) stock?
The financial health rating of LANXESS AG (LXS.DE) is 4 / 10.
Can you provide the expected EPS growth for LXS stock?
The Earnings per Share (EPS) of LANXESS AG (LXS.DE) is expected to decline by -70.38% in the next year.